Literature DB >> 19478201

Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.

Sabine Meurer1, Sylke Pioch, Tatjana Pabst, Nils Opitz, Peter M Schmidt, Tobias Beckhaus, Kristina Wagner, Simone Matt, Kristina Gegenbauer, Sandra Geschka, Michael Karas, Johannes-Peter Stasch, Harald H H W Schmidt, Werner Müller-Esterl.   

Abstract

Nitric oxide (NO) is an essential vasodilator. In vascular diseases, oxidative stress attenuates NO signaling by both chemical scavenging of free NO and oxidation and downregulation of its major intracellular receptor, the alphabeta heterodimeric heme-containing soluble guanylate cyclase (sGC). Oxidation can also induce loss of the heme of sGC, as well as the responsiveness of sGC to NO. sGC activators such as BAY 58-2667 bind to oxidized/heme-free sGC and reactivate the enzyme to exert disease-specific vasodilation. Here, we show that oxidation-induced downregulation of sGC protein extends to isolated blood vessels. Mechanistically, degradation was triggered through sGC ubiquitination and proteasomal degradation. The heme-binding site ligand BAY 58-2667 prevented sGC ubiquitination and stabilized both alpha and beta subunits. Collectively, our data establish oxidation-ubiquitination of sGC as a modulator of NO/cGMP signaling and point to a new mechanism of action for sGC activating vasodilators by stabilizing their receptor, oxidized/heme-free sGC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478201     DOI: 10.1161/CIRCRESAHA.109.198234

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  49 in total

1.  Oxidation and loss of heme in soluble guanylyl cyclase from Manduca sexta.

Authors:  Bradley G Fritz; Xiaohui Hu; Jacqueline L Brailey; Robert E Berry; F Ann Walker; William R Montfort
Journal:  Biochemistry       Date:  2011-06-10       Impact factor: 3.162

2.  Structural and functional insights into the heme-binding domain of the human soluble guanylate cyclase α2 subunit and heterodimeric α2β1.

Authors:  Hongyan Wang; Fangfang Zhong; Jie Pan; Wei Li; Jihu Su; Zhong-Xian Huang; Xiangshi Tan
Journal:  J Biol Inorg Chem       Date:  2012-03-18       Impact factor: 3.358

3.  Dynamic ligand exchange in soluble guanylyl cyclase (sGC): implications for sGC regulation and desensitization.

Authors:  Ah-Lim Tsai; Vladimir Berka; Iraida Sharina; Emil Martin
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

Review 4.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

5.  Ido brings down the pressure in systemic inflammation.

Authors:  Franz Hofmann
Journal:  Nat Med       Date:  2010-03       Impact factor: 53.440

Review 6.  The COP9 signalosome and vascular function: intriguing possibilities?

Authors:  Douglas S Martin; Xuejun Wang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

7.  Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.

Authors:  Fadi N Salloum; Anindita Das; Arun Samidurai; Nicholas N Hoke; Vinh Q Chau; Ramzi A Ockaili; Johannes-Peter Stasch; Rakesh C Kukreja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-20       Impact factor: 4.733

Review 8.  The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism.

Authors:  Javier Inserte; David Garcia-Dorado
Journal:  Br J Pharmacol       Date:  2015-03-16       Impact factor: 8.739

Review 9.  Structure and Activation of Soluble Guanylyl Cyclase, the Nitric Oxide Sensor.

Authors:  William R Montfort; Jessica A Wales; Andrzej Weichsel
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

Review 10.  Translating the oxidative stress hypothesis into the clinic: NOX versus NOS.

Authors:  Melanie E Armitage; Kirstin Wingler; Harald H H W Schmidt; Mylinh La
Journal:  J Mol Med (Berl)       Date:  2009-10-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.